Compare BUR & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BUR | PRGO |
|---|---|---|
| Founded | 2009 | 1887 |
| Country | Guernsey | Ireland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.8B |
| IPO Year | 2010 | 1991 |
| Metric | BUR | PRGO |
|---|---|---|
| Price | $8.92 | $12.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | $18.00 | ★ $22.50 |
| AVG Volume (30 Days) | 2.4M | ★ 3.8M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | 1.39% | ★ 8.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | $466,134,000.00 | ★ $4,281,800,000.00 |
| Revenue This Year | $13.60 | N/A |
| Revenue Next Year | $10.53 | N/A |
| P/E Ratio | $22.65 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.19 | $12.17 |
| 52 Week High | $15.73 | $30.93 |
| Indicator | BUR | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 30.82 |
| Support Level | $9.23 | $12.93 |
| Resistance Level | $9.30 | $13.63 |
| Average True Range (ATR) | 0.28 | 0.45 |
| MACD | 0.04 | 0.25 |
| Stochastic Oscillator | 10.87 | 1.53 |
Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.